...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >APPLICATION OF THE NEW OROSLIPPERY TECHNOLOGY IN THE PREPARATION OF ENTERIC SLIPPERY COATED TABLET OF NAPROXEN
【24h】

APPLICATION OF THE NEW OROSLIPPERY TECHNOLOGY IN THE PREPARATION OF ENTERIC SLIPPERY COATED TABLET OF NAPROXEN

机译:新型骨科学技术在制备萘普生肠溶性滑剂片剂中的应用

获取原文

摘要

Objective: The aim of this study was to formulate enteric coated oroslippery tablets (OSTs) of naproxen to overcome the common problems of stomach irritation and swallowing difficulties which accompanied the administration of naproxen tablets. Methods: Different formulas of enteric slippery tablets were prepared by direct compression method. Various parameters were investigated like the effect of eudragit L-100 (eud.) concentration (as an enteric polymer), coating level and effect of different concentrations of croscarmellose sodium CCS (as super disintegrant) on the physical properties. Finally, in an in vitro disintegration and release study was carried out. Results: The enteric slippery optimal formula (F8) was selected to consist of double coat (17.5% eudragit (eud.)) with core tablet containing (6% CCS). It was found that this optimal formula having an acceptable physical property (friability, hardness, thickness and weight variation). Besides, the best acid resistant potential represented by the protection of the OSTs for 2 h in 0.1 N HCl without any sign of disintegration and drug release. Moreover, it was found that (F8) has a disintegration time equal to (8±1.36 min) and release of 80% (20±0.18 min) in phosphate buffer pH 6.8. Conclusion: The result revealed the successful preparation of naproxen tablets using enteric slippery coating that can be easily swallowed and prevent direct irritation of the stomach with acceptable tablet weight.
机译:目的:本研究的目的是配制萘普生肠溶包衣口滑片(OSTs),以克服伴随萘普生片服用引起的胃部刺激和吞咽困难的常见问题。方法:采用直接压片法制备不同配方的肠溶性片剂。研究了各种参数,例如eudragit L-100(eud。)浓度(作为肠溶聚合物)的影响,包衣水平和不同浓度的交联羧甲基纤维素钠CCS(作为超级崩解剂)对物理性能的影响。最后,在体外进行了崩解和释放研究。结果:选择的肠溶性滑爽最佳配方(F8)由双层包衣(17.5%eudragit(eud。))和含(6%CCS)的核心片剂组成。发现该最佳配方具有可接受的物理性质(脆性,硬度,厚度和重量变化)。此外,以OSTs在0.1 N HCl中的2小时保护表现出最佳的耐酸潜力,没有任何崩解和药物释放的迹象。此外,发现(F8)在pH 6.8的磷酸盐缓冲液中具有等于(8±1.36min)的崩解时间和80%的释放(20±0.18min)。结论:结果表明,肠溶性光滑包衣成功地制备了萘普生片剂,该片剂易于吞咽并能以可接受的片剂重量防止对胃的直接刺激。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号